Send us Feedback

Keryx Biopharmaceuticals (KERX)
Analysis
Data
Financials
 
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 6.78M 13.1M 13.1M 13.4M 33.7M
Short Term Investments 10.3M 2.30M 2.30M 0 0
Accounts Receivable 222K 25K 50K 4K 5K
Inventories 0 0 0 0 0
Pre-paid Expenses 0 0 0 0 0
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 684K 508K 455K 222K 1.03M
Total Current Assets 18.0M 16.0M 15.9M 13.6M 34.7M
Property, Plant & Equipment 208K 182K 157K 137K 114K
Goodwill & Intangibles 3.21M 3.21M 3.21M 3.21M 3.21M
Other Long-term Assets 9.30M 7.27M 7.18M 7.18M 7.41M
Total Long-Term Assets 12.7M 10.7M 10.5M 10.5M 10.7M
Total Assets 30.7M 26.6M 26.4M 24.2M 45.5M
Accounts Payable 6.00M 4.61M 4.10M 4.15M 3.78M
Accrued Expenses 0 0 0 0 0
Short Term Debt 0 0 0 0 0
Other Current Liabilities 1.58M 1.58M 1.58M 156K 276K
Total Current Liabilities 8.61M 6.69M 5.83M 5.02M 6.43M
Long Term Debt 0 0 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 21.8M 21.4M 21.1M 4.09M 4.07M
Total Long-term Liabilities 21.8M 21.4M 21.1M 4.09M 4.07M
Minority Interest 0 0 0 0 0
Total Liabilities 30.4M 28.1M 26.9M 9.11M 10.5M
Preferred Stock 0 0 0 0 0
Common Par 45K 48K 48K 48K 56K
Additional Paid-In Capital 328M 331M 331M 333M 352M
Retained Earnings -327M -332M -331M -317M -317M
Treasury Stock -357K -357K -357K -357K -357K
Other Equity 0 0 0 0 250K
Total Shareholder's Equity 321K -1.49M -467K 15.1M 35.0M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki